Drug
Jnj 31001074
Jnj 31001074: highest development phase Phase 1, developed by Johnson & Johnson. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Johnson & Johnson
Trials
| Drug | Phase | Indication |
|---|---|---|
| JNJ-31001074 NCT00915668 | Phase 1 | Pharmacokinetics |
Latest
No recent events.
Follow Jnj 31001074 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.